Stock RX BIOSYENT INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News BioSyent Inc.

Equities

RX

CA0906901081

Market Closed - Toronto S.E.
Other stock markets
 20:54:42 20/06/2024 BST 		5-day change 1st Jan Change
10.01 CAD +8.69% Intraday chart for BioSyent Inc. +1.62% +8.57%
05-17 Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. CI
05-17 BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioSyent In-Licenses Endocrinology Product for Canada
GL
Ex-dividend day
FA
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.
CI
BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
BioSyent Releases Financial Results for Q1 2024
GL
BioSyent Declares Second Quarter 2024 Dividend
GL
BioSyent Inc Declares Second Quarter 2024 Dividend, Payable June 15, 2024
CI
BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024
GL
BioSyent to Attend Planet MicroCap Showcase
GL
BioSyent Inc.(TSXV:RX) dropped from S&P/TSX Venture Composite Index
CI
BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement
GL
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
GL
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year
GL
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year
AQ
BioSyent To Present At LD Micro New York Investor Conference
MT
BioSyent to Present at LD Micro New York Investor Conference
GL
BioSyent Announces Grant of Restricted Share Units
GL
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2022.
CI
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.
CI
BioSyent Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RX Stock
  4. News BioSyent Inc.